Canakinumab for treatment of cryopyrin-associated periodic syndrome

Bibliography

• Kile RL, Rusk HA. A case of cold urticaria with an unusual family history. JAMA 1940;114:1067-8
   Google Scholar
• Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 1962;31:235-48
   PubMedGoogle Scholar
• Prieur AM, Griscelli C. Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediatr 1981;99(1):79-83
   PubMed Web of Science ®Google Scholar
• Hoffman HM, Wright FA, Broide DH, Identification of a locus on chromosome 1q44 for familial cold urticaria. Am J Hum Genet 2000;66(5):1693-8
   PubMed Web of Science ®Google Scholar
• Cuisset L, Drenth JP, Berthelot JM, Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet 1999;65(4):1054-9
   PubMed Web of Science ®Google Scholar
• McDermott MF, Aganna E, Hitman GA, An autosomal dominant periodic fever associated with AA amyloidosis in a north Indian family maps to distal chromosome 1q. Arthritis Rheum 2000;43(9):2034-40
   PubMed Web of Science ®Google Scholar
• Aganna E, Martinon F, Hawkins PN, Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 2002;46(9):2445-52
   PubMed Web of Science ®Google Scholar
• Farasat S, Aksentijevich I, Toro JR. Autoinflammatory diseases: clinical and genetic advances. Arch Dermatol 2008;144(3):392-402
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Lowe P, Felix SD, In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes. J Exp Med 2009;206(5):1029-36
   PubMed Web of Science ®Google Scholar
• Agostini L, Martinon F, Burns K, NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 2004;20(3):319-25
   PubMed Web of Science ®Google Scholar
• Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 2008;4(1):34-42
   PubMedGoogle Scholar
• Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med 2005;201(9):1355-9
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Hawkins PN. Developments in the scientific and clinical understanding of autoinflammatory disorders. Arthritis Res Ther 2009;11(1):212
   PubMedGoogle Scholar
• Stych B, Dobrovolny D. Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives. Curr Med Res Opin 2008;24(6):1577-82
   PubMed Web of Science ®Google Scholar
• Hawkins PN, Lachmann HJ, McDermott MF. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003;348(25):2583-4
   PubMed Web of Science ®Google Scholar
• Glaser RL, Goldbach-Mansky R. The spectrum of monogenic autoinflammatory syndromes: understanding disease mechanisms and use of targeted therapies. Curr Allergy Asthma Rep 2008;8(4):288-98
   PubMed Web of Science ®Google Scholar
• Federico G, Rigante D, Pugliese AL, Etanercept induces improvement of arthropathy in chronic infantile neurological cutaneous articular (CINCA) syndrome. Scand J Rheumatol 2003;32(5):312-4
   PubMed Web of Science ®Google Scholar
• Matsubayashi T, Sugiura H, Arai T, Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene. Acta Paediatr 2006;95(2):246-9
   PubMed Web of Science ®Google Scholar
• Goldbach-Mansky R, Dailey NJ, Canna SW, Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006;355(6):581-92
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 2009;360(23):2416-25
   PubMed Web of Science ®Google Scholar
• So A, De Meulemeester M, Pikhlak A, Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis. Arthritis Rheum 2010;62(10):3064-76
   Google Scholar
• Toker O, Hashkes PJ. Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS). Biologics 2010;4:131-8
   PubMedGoogle Scholar
• Alten R, Gram H, Joosten LA, The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res Ther 2008;10(3):R67
   PubMedGoogle Scholar
• Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50(2):607-12
   PubMed Web of Science ®Google Scholar
• Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 2001;108(4):615-20
   PubMed Web of Science ®Google Scholar
• Church LD, McDermott MF. Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. Curr Opin Mol Ther 2009;11(1):81-9
   PubMed Web of Science ®Google Scholar
• Geyer M, Muller-Ladner U. Actual status of antiinterleukin-1 therapies in rheumatic diseases. Curr Opin Rheumatol 2010;22(3):246-51
   PubMed Web of Science ®Google Scholar